Biosimilars and Biobetters: More than Generic Biologicals
- Date:
- 27 April 2015
- Time:
- -
- Available Seats:
- 30
Learning Objectives:
● Define biosimilars and biobetters.
● Identify at least two (2) key differences in the development of biosimilars/ biobetters compared to the innovator product.
● List at least two (2) challenges to clinical supplies for studies supporting biosimilar/ biobetter development
